Skip to content
buyWeak cluster of 410b5-1 plan

Kenneth Krogulski bought $4,548 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 875 shares at an average of $5.20, traded Mar 3, 2025, filed Apr 4, 2025.

Conviction score
14
Value
$4,548
875 shares
Holdings after
283,718
+0% from before
From 52-week low
+385%
low $0.82, close $3.99
From 52-week high
-17%
high $4.80, as of Mar 3, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $5k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.3%)
    -5
  • Price context
    17% below the 52-week high
    +4
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing Apr 4, 2025: +114.3%SPY +56.6% · excess +57.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-016741, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2025POpen-market purchase
Common Stock10b5-1
+47$5.54$260282,890Apr 4, 2025
Mar 4, 2025POpen-market purchase
Common Stock10b5-1
+47$5.11$240282,937Apr 4, 2025
Mar 5, 2025POpen-market purchase
Common Stock10b5-1
+47$6.75$317282,984Apr 4, 2025
Mar 6, 2025POpen-market purchase
Common Stock10b5-1
+47$6.57$309283,031Apr 4, 2025
Mar 7, 2025POpen-market purchase
Common Stock10b5-1
+47$6.51$306283,078Apr 4, 2025
Mar 10, 2025POpen-market purchase
Common Stock10b5-1
+37$5.85$216283,115Apr 4, 2025
Mar 11, 2025POpen-market purchase
Common Stock10b5-1
+37$4.85$179283,152Apr 4, 2025
Mar 12, 2025POpen-market purchase
Common Stock10b5-1
+37$5.17$191283,189Apr 4, 2025
Mar 13, 2025POpen-market purchase
Common Stock10b5-1
+37$5.47$202283,226Apr 4, 2025
Mar 14, 2025POpen-market purchase
Common Stock10b5-1
+37$5.38$199283,263Apr 4, 2025
Mar 17, 2025POpen-market purchase
Common Stock10b5-1
+37$5.41$200283,300Apr 4, 2025
Mar 18, 2025POpen-market purchase
Common Stock10b5-1
+37$5.12$189283,337Apr 4, 2025
Mar 19, 2025POpen-market purchase
Common Stock10b5-1
+37$5.41$200283,374Apr 4, 2025
Mar 20, 2025POpen-market purchase
Common Stock10b5-1
+37$5.07$188283,411Apr 4, 2025
Mar 21, 2025POpen-market purchase
Common Stock10b5-1
+37$4.89$181283,448Apr 4, 2025
Mar 24, 2025POpen-market purchase
Common Stock10b5-1
+45$4.42$199283,493Apr 4, 2025
Mar 25, 2025POpen-market purchase
Common Stock10b5-1
+45$4.45$200283,538Apr 4, 2025
Mar 26, 2025POpen-market purchase
Common Stock10b5-1
+45$4.41$198283,583Apr 4, 2025
Mar 27, 2025POpen-market purchase
Common Stock10b5-1
+45$4.20$189283,628Apr 4, 2025
Mar 28, 2025POpen-market purchase
Common Stock10b5-1
+45$4.20$189283,673Apr 4, 2025
Mar 31, 2025POpen-market purchase
Common Stock10b5-1
+45$4.29$193283,718Apr 4, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
29Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$858
168 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$429
84 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$858
168 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,824
945 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,635
1,035 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$833
186 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$833
186 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$417
93 shares
+0%
24Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$881
168 shares
+0%
14Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$881
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kenneth Krogulski bought $4,548 of CPIX | InsiderTell